 | • レポートコード：QYR2104Z5009 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、133ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、呼吸器合胞体ウイルス診断のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（直接蛍光抗体法、迅速抗原診断検査、分子診断、クロマトグラフィーイムノアッセイ、画像診断、ゲル微小滴、フローサイトメトリー、その他）、用途別市場規模（病院、検査室、診療所、在宅医療）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・呼吸器合胞体ウイルス診断の市場動向 ・企業の競争状況、市場シェア ・呼吸器合胞体ウイルス診断の種類別市場規模（直接蛍光抗体法、迅速抗原診断検査、分子診断、クロマトグラフィーイムノアッセイ、画像診断、ゲル微小滴、フローサイトメトリー、その他） ・呼吸器合胞体ウイルス診断の用途別市場規模（病院、検査室、診療所、在宅医療） ・呼吸器合胞体ウイルス診断の北米市場規模2016-2027（アメリカ、カナダ） ・呼吸器合胞体ウイルス診断のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・呼吸器合胞体ウイルス診断のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・呼吸器合胞体ウイルス診断の中南米市場規模2016-2027（メキシコ、ブラジル） ・呼吸器合胞体ウイルス診断の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Becton Dickinson、Abbott Laboratories、Abbott、Beckman Coulter/Danaher、Bio-Rad Laboratories、Coris BioConcept、DiaSorin SPA、Eiken Chemical、Elitech、Fujirebio、Grifols、Hoffmann La Roche、Hologic、Novartis Diagnostics、Ortho Clinical Diagnostics、Roche Diagnostics、Scienion） ・結論 |
Products of the respiratory syncytial virus diagnostics market includes direct fluorescent antibody (DFA) method, rapid antigen diagnostic test (RADTs), molecular diagnostics, chromatographic immunoassay, diagnostic imaging, gel microdroplets, flow cytometry, and others.
North America dominates the market for respiratory syncytial virus diagnosis because of the rising incidence of these infections and the increasing number of babies. In addition, the medical system continues to evolve, and more and more government initiatives, China, India, Japan and Malaysia are expected to become the fastest growing markets in the region.
Market Analysis and Insights: Global Respiratory Syncytial Virus Diagnostics Market
The global Respiratory Syncytial Virus Diagnostics market size is projected to reach US$ 837.1 million by 2026, from US$ 564.4 million in 2019, at a CAGR of 5.7% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Respiratory Syncytial Virus Diagnostics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Respiratory Syncytial Virus Diagnostics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Respiratory Syncytial Virus Diagnostics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Respiratory Syncytial Virus Diagnostics market.
Global Respiratory Syncytial Virus Diagnostics Scope and Market Size
Respiratory Syncytial Virus Diagnostics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Respiratory Syncytial Virus Diagnostics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Direct Fluorescent Antibody Method
Rapid Antigen Diagnostic Tests
Molecular Diagnostics
Chromatographic Immunoassay
Diagnostic Imaging
Gel Microdroplets
Flow Cytometry
Other
Segment by Application
Hospitals
Laboratory
Clinics
Homecare
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Becton Dickinson
Abbott Laboratories
Abbott
Beckman Coulter/Danaher
Bio-Rad Laboratories
Coris BioConcept
DiaSorin SPA
Eiken Chemical
Elitech
Beckman Coulter/Danaher
Bio-Rad Laboratories
Hoffmann La Roche
Hologic
Novartis Diagnostics
Ortho Clinical Diagnostics
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Respiratory Syncytial Virus Diagnostics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Direct Fluorescent Antibody Method
1.2.3 Rapid Antigen Diagnostic Tests
1.2.4 Molecular Diagnostics
1.2.5 Chromatographic Immunoassay
1.2.6 Diagnostic Imaging
1.2.7 Gel Microdroplets
1.2.8 Flow Cytometry
1.2.9 Other
1.3 Market by Application
1.3.1 Global Respiratory Syncytial Virus Diagnostics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Laboratory
1.3.4 Clinics
1.3.5 Homecare
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Respiratory Syncytial Virus Diagnostics Market Perspective (2016-2027)
2.2 Respiratory Syncytial Virus Diagnostics Growth Trends by Regions
2.2.1 Respiratory Syncytial Virus Diagnostics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Respiratory Syncytial Virus Diagnostics Historic Market Share by Regions (2016-2021)
2.2.3 Respiratory Syncytial Virus Diagnostics Forecasted Market Size by Regions (2022-2027)
2.3 Respiratory Syncytial Virus Diagnostics Industry Dynamic
2.3.1 Respiratory Syncytial Virus Diagnostics Market Trends
2.3.2 Respiratory Syncytial Virus Diagnostics Market Drivers
2.3.3 Respiratory Syncytial Virus Diagnostics Market Challenges
2.3.4 Respiratory Syncytial Virus Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Respiratory Syncytial Virus Diagnostics Players by Revenue
3.1.1 Global Top Respiratory Syncytial Virus Diagnostics Players by Revenue (2016-2021)
3.1.2 Global Respiratory Syncytial Virus Diagnostics Revenue Market Share by Players (2016-2021)
3.2 Global Respiratory Syncytial Virus Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Respiratory Syncytial Virus Diagnostics Revenue
3.4 Global Respiratory Syncytial Virus Diagnostics Market Concentration Ratio
3.4.1 Global Respiratory Syncytial Virus Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Respiratory Syncytial Virus Diagnostics Revenue in 2020
3.5 Respiratory Syncytial Virus Diagnostics Key Players Head office and Area Served
3.6 Key Players Respiratory Syncytial Virus Diagnostics Product Solution and Service
3.7 Date of Enter into Respiratory Syncytial Virus Diagnostics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Respiratory Syncytial Virus Diagnostics Breakdown Data by Type
4.1 Global Respiratory Syncytial Virus Diagnostics Historic Market Size by Type (2016-2021)
4.2 Global Respiratory Syncytial Virus Diagnostics Forecasted Market Size by Type (2022-2027)
5 Respiratory Syncytial Virus Diagnostics Breakdown Data by Application
5.1 Global Respiratory Syncytial Virus Diagnostics Historic Market Size by Application (2016-2021)
5.2 Global Respiratory Syncytial Virus Diagnostics Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Respiratory Syncytial Virus Diagnostics Market Size (2016-2027)
6.2 North America Respiratory Syncytial Virus Diagnostics Market Size by Type
6.2.1 North America Respiratory Syncytial Virus Diagnostics Market Size by Type (2016-2021)
6.2.2 North America Respiratory Syncytial Virus Diagnostics Market Size by Type (2022-2027)
6.2.3 North America Respiratory Syncytial Virus Diagnostics Market Size by Type (2016-2027)
6.3 North America Respiratory Syncytial Virus Diagnostics Market Size by Application
6.3.1 North America Respiratory Syncytial Virus Diagnostics Market Size by Application (2016-2021)
6.3.2 North America Respiratory Syncytial Virus Diagnostics Market Size by Application (2022-2027)
6.3.3 North America Respiratory Syncytial Virus Diagnostics Market Size by Application (2016-2027)
6.4 North America Respiratory Syncytial Virus Diagnostics Market Size by Country
6.4.1 North America Respiratory Syncytial Virus Diagnostics Market Size by Country (2016-2021)
6.4.2 North America Respiratory Syncytial Virus Diagnostics Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Respiratory Syncytial Virus Diagnostics Market Size (2016-2027)
7.2 Europe Respiratory Syncytial Virus Diagnostics Market Size by Type
7.2.1 Europe Respiratory Syncytial Virus Diagnostics Market Size by Type (2016-2021)
7.2.2 Europe Respiratory Syncytial Virus Diagnostics Market Size by Type (2022-2027)
7.2.3 Europe Respiratory Syncytial Virus Diagnostics Market Size by Type (2016-2027)
7.3 Europe Respiratory Syncytial Virus Diagnostics Market Size by Application
7.3.1 Europe Respiratory Syncytial Virus Diagnostics Market Size by Application (2016-2021)
7.3.2 Europe Respiratory Syncytial Virus Diagnostics Market Size by Application (2022-2027)
7.3.3 Europe Respiratory Syncytial Virus Diagnostics Market Size by Application (2016-2027)
7.4 Europe Respiratory Syncytial Virus Diagnostics Market Size by Country
7.4.1 Europe Respiratory Syncytial Virus Diagnostics Market Size by Country (2016-2021)
7.4.2 Europe Respiratory Syncytial Virus Diagnostics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Respiratory Syncytial Virus Diagnostics Market Size (2016-2027)
8.2 Asia-Pacific Respiratory Syncytial Virus Diagnostics Market Size by Type
8.2.1 Asia-Pacific Respiratory Syncytial Virus Diagnostics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Respiratory Syncytial Virus Diagnostics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Respiratory Syncytial Virus Diagnostics Market Size by Type (2016-2027)
8.3 Asia-Pacific Respiratory Syncytial Virus Diagnostics Market Size by Application
8.3.1 Asia-Pacific Respiratory Syncytial Virus Diagnostics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Respiratory Syncytial Virus Diagnostics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Respiratory Syncytial Virus Diagnostics Market Size by Application (2016-2027)
8.4 Asia-Pacific Respiratory Syncytial Virus Diagnostics Market Size by Region
8.4.1 Asia-Pacific Respiratory Syncytial Virus Diagnostics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Respiratory Syncytial Virus Diagnostics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Respiratory Syncytial Virus Diagnostics Market Size (2016-2027)
9.2 Latin America Respiratory Syncytial Virus Diagnostics Market Size by Type
9.2.1 Latin America Respiratory Syncytial Virus Diagnostics Market Size by Type (2016-2021)
9.2.2 Latin America Respiratory Syncytial Virus Diagnostics Market Size by Type (2022-2027)
9.2.3 Latin America Respiratory Syncytial Virus Diagnostics Market Size by Type (2016-2027)
9.3 Latin America Respiratory Syncytial Virus Diagnostics Market Size by Application
9.3.1 Latin America Respiratory Syncytial Virus Diagnostics Market Size by Application (2016-2021)
9.3.2 Latin America Respiratory Syncytial Virus Diagnostics Market Size by Application (2022-2027)
9.3.3 Latin America Respiratory Syncytial Virus Diagnostics Market Size by Application (2016-2027)
9.4 Latin America Respiratory Syncytial Virus Diagnostics Market Size by Country
9.4.1 Latin America Respiratory Syncytial Virus Diagnostics Market Size by Country (2016-2021)
9.4.2 Latin America Respiratory Syncytial Virus Diagnostics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Respiratory Syncytial Virus Diagnostics Market Size (2016-2027)
10.2 Middle East & Africa Respiratory Syncytial Virus Diagnostics Market Size by Type
10.2.1 Middle East & Africa Respiratory Syncytial Virus Diagnostics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Respiratory Syncytial Virus Diagnostics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Respiratory Syncytial Virus Diagnostics Market Size by Type (2016-2027)
10.3 Middle East & Africa Respiratory Syncytial Virus Diagnostics Market Size by Application
10.3.1 Middle East & Africa Respiratory Syncytial Virus Diagnostics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Respiratory Syncytial Virus Diagnostics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Respiratory Syncytial Virus Diagnostics Market Size by Application (2016-2027)
10.4 Middle East & Africa Respiratory Syncytial Virus Diagnostics Market Size by Country
10.4.1 Middle East & Africa Respiratory Syncytial Virus Diagnostics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Respiratory Syncytial Virus Diagnostics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Becton Dickinson
11.1.1 Becton Dickinson Company Details
11.1.2 Becton Dickinson Business Overview
11.1.3 Becton Dickinson Respiratory Syncytial Virus Diagnostics Introduction
11.1.4 Becton Dickinson Revenue in Respiratory Syncytial Virus Diagnostics Business (2016-2021)
11.1.5 Becton Dickinson Recent Development
11.2 Abbott Laboratories
11.2.1 Abbott Laboratories Company Details
11.2.2 Abbott Laboratories Business Overview
11.2.3 Abbott Laboratories Respiratory Syncytial Virus Diagnostics Introduction
11.2.4 Abbott Laboratories Revenue in Respiratory Syncytial Virus Diagnostics Business (2016-2021)
11.2.5 Abbott Laboratories Recent Development
11.3 Abbott
11.3.1 Abbott Company Details
11.3.2 Abbott Business Overview
11.3.3 Abbott Respiratory Syncytial Virus Diagnostics Introduction
11.3.4 Abbott Revenue in Respiratory Syncytial Virus Diagnostics Business (2016-2021)
11.3.5 Abbott Recent Development
11.4 Beckman Coulter/Danaher
11.4.1 Beckman Coulter/Danaher Company Details
11.4.2 Beckman Coulter/Danaher Business Overview
11.4.3 Beckman Coulter/Danaher Respiratory Syncytial Virus Diagnostics Introduction
11.4.4 Beckman Coulter/Danaher Revenue in Respiratory Syncytial Virus Diagnostics Business (2016-2021)
11.4.5 Beckman Coulter/Danaher Recent Development
11.5 Bio-Rad Laboratories
11.5.1 Bio-Rad Laboratories Company Details
11.5.2 Bio-Rad Laboratories Business Overview
11.5.3 Bio-Rad Laboratories Respiratory Syncytial Virus Diagnostics Introduction
11.5.4 Bio-Rad Laboratories Revenue in Respiratory Syncytial Virus Diagnostics Business (2016-2021)
11.5.5 Bio-Rad Laboratories Recent Development
11.6 Coris BioConcept
11.6.1 Coris BioConcept Company Details
11.6.2 Coris BioConcept Business Overview
11.6.3 Coris BioConcept Respiratory Syncytial Virus Diagnostics Introduction
11.6.4 Coris BioConcept Revenue in Respiratory Syncytial Virus Diagnostics Business (2016-2021)
11.6.5 Coris BioConcept Recent Development
11.7 DiaSorin SPA
11.7.1 DiaSorin SPA Company Details
11.7.2 DiaSorin SPA Business Overview
11.7.3 DiaSorin SPA Respiratory Syncytial Virus Diagnostics Introduction
11.7.4 DiaSorin SPA Revenue in Respiratory Syncytial Virus Diagnostics Business (2016-2021)
11.7.5 DiaSorin SPA Recent Development
11.8 Eiken Chemical
11.8.1 Eiken Chemical Company Details
11.8.2 Eiken Chemical Business Overview
11.8.3 Eiken Chemical Respiratory Syncytial Virus Diagnostics Introduction
11.8.4 Eiken Chemical Revenue in Respiratory Syncytial Virus Diagnostics Business (2016-2021)
11.8.5 Eiken Chemical Recent Development
11.9 Elitech
11.9.1 Elitech Company Details
11.9.2 Elitech Business Overview
11.9.3 Elitech Respiratory Syncytial Virus Diagnostics Introduction
11.9.4 Elitech Revenue in Respiratory Syncytial Virus Diagnostics Business (2016-2021)
11.9.5 Elitech Recent Development
11.10 Fujirebio
11.10.1 Fujirebio Company Details
11.10.2 Fujirebio Business Overview
11.10.3 Fujirebio Respiratory Syncytial Virus Diagnostics Introduction
11.10.4 Fujirebio Revenue in Respiratory Syncytial Virus Diagnostics Business (2016-2021)
11.10.5 Fujirebio Recent Development
11.11 Grifols
11.11.1 Grifols Company Details
11.11.2 Grifols Business Overview
11.11.3 Grifols Respiratory Syncytial Virus Diagnostics Introduction
11.11.4 Grifols Revenue in Respiratory Syncytial Virus Diagnostics Business (2016-2021)
11.11.5 Grifols Recent Development
11.12 Hoffmann La Roche
11.12.1 Hoffmann La Roche Company Details
11.12.2 Hoffmann La Roche Business Overview
11.12.3 Hoffmann La Roche Respiratory Syncytial Virus Diagnostics Introduction
11.12.4 Hoffmann La Roche Revenue in Respiratory Syncytial Virus Diagnostics Business (2016-2021)
11.12.5 Hoffmann La Roche Recent Development
11.13 Hologic
11.13.1 Hologic Company Details
11.13.2 Hologic Business Overview
11.13.3 Hologic Respiratory Syncytial Virus Diagnostics Introduction
11.13.4 Hologic Revenue in Respiratory Syncytial Virus Diagnostics Business (2016-2021)
11.13.5 Hologic Recent Development
11.14 Novartis Diagnostics
11.14.1 Novartis Diagnostics Company Details
11.14.2 Novartis Diagnostics Business Overview
11.14.3 Novartis Diagnostics Respiratory Syncytial Virus Diagnostics Introduction
11.14.4 Novartis Diagnostics Revenue in Respiratory Syncytial Virus Diagnostics Business (2016-2021)
11.14.5 Novartis Diagnostics Recent Development
11.15 Ortho Clinical Diagnostics
11.15.1 Ortho Clinical Diagnostics Company Details
11.15.2 Ortho Clinical Diagnostics Business Overview
11.15.3 Ortho Clinical Diagnostics Respiratory Syncytial Virus Diagnostics Introduction
11.15.4 Ortho Clinical Diagnostics Revenue in Respiratory Syncytial Virus Diagnostics Business (2016-2021)
11.15.5 Ortho Clinical Diagnostics Recent Development
11.16 Roche Diagnostics
11.16.1 Roche Diagnostics Company Details
11.16.2 Roche Diagnostics Business Overview
11.16.3 Roche Diagnostics Respiratory Syncytial Virus Diagnostics Introduction
11.16.4 Roche Diagnostics Revenue in Respiratory Syncytial Virus Diagnostics Business (2016-2021)
11.16.5 Roche Diagnostics Recent Development
11.17 Scienion
11.17.1 Scienion Company Details
11.17.2 Scienion Business Overview
11.17.3 Scienion Respiratory Syncytial Virus Diagnostics Introduction
11.17.4 Scienion Revenue in Respiratory Syncytial Virus Diagnostics Business (2016-2021)
11.17.5 Scienion Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Respiratory Syncytial Virus Diagnostics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Direct Fluorescent Antibody Method
Table 3. Key Players of Rapid Antigen Diagnostic Tests
Table 4. Key Players of Molecular Diagnostics
Table 5. Key Players of Chromatographic Immunoassay
Table 6. Key Players of Diagnostic Imaging
Table 7. Key Players of Gel Microdroplets
Table 8. Key Players of Flow Cytometry
Table 9. Key Players of Other
Table 10. Global Respiratory Syncytial Virus Diagnostics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 11. Global Respiratory Syncytial Virus Diagnostics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 12. Global Respiratory Syncytial Virus Diagnostics Market Size by Regions (2016-2021) & (US$ Million)
Table 13. Global Respiratory Syncytial Virus Diagnostics Market Share by Regions (2016-2021)
Table 14. Global Respiratory Syncytial Virus Diagnostics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 15. Global Respiratory Syncytial Virus Diagnostics Market Share by Regions (2022-2027)
Table 16. Respiratory Syncytial Virus Diagnostics Market Trends
Table 17. Respiratory Syncytial Virus Diagnostics Market Drivers
Table 18. Respiratory Syncytial Virus Diagnostics Market Challenges
Table 19. Respiratory Syncytial Virus Diagnostics Market Restraints
Table 20. Global Respiratory Syncytial Virus Diagnostics Revenue by Players (2016-2021) & (US$ Million)
Table 21. Global Respiratory Syncytial Virus Diagnostics Market Share by Players (2016-2021)
Table 22. Global Top Respiratory Syncytial Virus Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Respiratory Syncytial Virus Diagnostics as of 2020)
Table 23. Ranking of Global Top Respiratory Syncytial Virus Diagnostics Companies by Revenue (US$ Million) in 2020
Table 24. Global 5 Largest Players Market Share by Respiratory Syncytial Virus Diagnostics Revenue (CR5 and HHI) & (2016-2021)
Table 25. Key Players Headquarters and Area Served
Table 26. Key Players Respiratory Syncytial Virus Diagnostics Product Solution and Service
Table 27. Date of Enter into Respiratory Syncytial Virus Diagnostics Market
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Respiratory Syncytial Virus Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 30. Global Respiratory Syncytial Virus Diagnostics Revenue Market Share by Type (2016-2021)
Table 31. Global Respiratory Syncytial Virus Diagnostics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 32. Global Respiratory Syncytial Virus Diagnostics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 33. Global Respiratory Syncytial Virus Diagnostics Market Size Share by Application (2016-2021) & (US$ Million)
Table 34. Global Respiratory Syncytial Virus Diagnostics Revenue Market Share by Application (2016-2021)
Table 35. Global Respiratory Syncytial Virus Diagnostics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 36. Global Respiratory Syncytial Virus Diagnostics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 37. North America Respiratory Syncytial Virus Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 38. North America Respiratory Syncytial Virus Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 39. North America Respiratory Syncytial Virus Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 40. North America Respiratory Syncytial Virus Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 41. North America Respiratory Syncytial Virus Diagnostics Market Size by Country (2016-2021) & (US$ Million)
Table 42. North America Respiratory Syncytial Virus Diagnostics Market Size by Country (2022-2027) & (US$ Million)
Table 43. Europe Respiratory Syncytial Virus Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 44. Europe Respiratory Syncytial Virus Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 45. Europe Respiratory Syncytial Virus Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 46. Europe Respiratory Syncytial Virus Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 47. Europe Respiratory Syncytial Virus Diagnostics Market Size by Country (2016-2021) & (US$ Million)
Table 48. Europe Respiratory Syncytial Virus Diagnostics Market Size by Country (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Respiratory Syncytial Virus Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 50. Asia-Pacific Respiratory Syncytial Virus Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 51. Asia-Pacific Respiratory Syncytial Virus Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 52. Asia-Pacific Respiratory Syncytial Virus Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 53. Asia-Pacific Respiratory Syncytial Virus Diagnostics Market Size by Region (2016-2021) & (US$ Million)
Table 54. Asia-Pacific Respiratory Syncytial Virus Diagnostics Market Size by Region (2022-2027) & (US$ Million)
Table 55. Latin America Respiratory Syncytial Virus Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 56. Latin America Respiratory Syncytial Virus Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 57. Latin America Respiratory Syncytial Virus Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 58. Latin America Respiratory Syncytial Virus Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 59. Latin America Respiratory Syncytial Virus Diagnostics Market Size by Country (2016-2021) & (US$ Million)
Table 60. Latin America Respiratory Syncytial Virus Diagnostics Market Size by Country (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Respiratory Syncytial Virus Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 62. Middle East & Africa Respiratory Syncytial Virus Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 63. Middle East & Africa Respiratory Syncytial Virus Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 64. Middle East & Africa Respiratory Syncytial Virus Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 65. Middle East & Africa Respiratory Syncytial Virus Diagnostics Market Size by Country (2016-2021) & (US$ Million)
Table 66. Middle East & Africa Respiratory Syncytial Virus Diagnostics Market Size by Country (2022-2027) & (US$ Million)
Table 67. Becton Dickinson Company Details
Table 68. Becton Dickinson Business Overview
Table 69. Becton Dickinson Respiratory Syncytial Virus Diagnostics Product
Table 70. Becton Dickinson Revenue in Respiratory Syncytial Virus Diagnostics Business (2016-2021) & (US$ Million)
Table 71. Becton Dickinson Recent Development
Table 72. Abbott Laboratories Company Details
Table 73. Abbott Laboratories Business Overview
Table 74. Abbott Laboratories Respiratory Syncytial Virus Diagnostics Product
Table 75. Abbott Laboratories Revenue in Respiratory Syncytial Virus Diagnostics Business (2016-2021) & (US$ Million)
Table 76. Abbott Laboratories Recent Development
Table 77. Abbott Company Details
Table 78. Abbott Business Overview
Table 79. Abbott Respiratory Syncytial Virus Diagnostics Product
Table 80. Abbott Revenue in Respiratory Syncytial Virus Diagnostics Business (2016-2021) & (US$ Million)
Table 81. Abbott Recent Development
Table 82. Beckman Coulter/Danaher Company Details
Table 83. Beckman Coulter/Danaher Business Overview
Table 84. Beckman Coulter/Danaher Respiratory Syncytial Virus Diagnostics Product
Table 85. Beckman Coulter/Danaher Revenue in Respiratory Syncytial Virus Diagnostics Business (2016-2021) & (US$ Million)
Table 86. Beckman Coulter/Danaher Recent Development
Table 87. Bio-Rad Laboratories Company Details
Table 88. Bio-Rad Laboratories Business Overview
Table 89. Bio-Rad Laboratories Respiratory Syncytial Virus Diagnostics Product
Table 90. Bio-Rad Laboratories Revenue in Respiratory Syncytial Virus Diagnostics Business (2016-2021) & (US$ Million)
Table 91. Bio-Rad Laboratories Recent Development
Table 92. Coris BioConcept Company Details
Table 93. Coris BioConcept Business Overview
Table 94. Coris BioConcept Respiratory Syncytial Virus Diagnostics Product
Table 95. Coris BioConcept Revenue in Respiratory Syncytial Virus Diagnostics Business (2016-2021) & (US$ Million)
Table 96. Coris BioConcept Recent Development
Table 97. DiaSorin SPA Company Details
Table 98. DiaSorin SPA Business Overview
Table 99. DiaSorin SPA Respiratory Syncytial Virus Diagnostics Product
Table 100. DiaSorin SPA Revenue in Respiratory Syncytial Virus Diagnostics Business (2016-2021) & (US$ Million)
Table 101. DiaSorin SPA Recent Development
Table 102. Eiken Chemical Company Details
Table 103. Eiken Chemical Business Overview
Table 104. Eiken Chemical Revenue in Respiratory Syncytial Virus Diagnostics Business (2016-2021) & (US$ Million)
Table 105. Eiken Chemical Recent Development
Table 106. Elitech Company Details
Table 107. Elitech Business Overview
Table 108. Elitech Respiratory Syncytial Virus Diagnostics Product
Table 109. Elitech Revenue in Respiratory Syncytial Virus Diagnostics Business (2016-2021) & (US$ Million)
Table 110. Elitech Recent Development
Table 111. Fujirebio Company Details
Table 112. Fujirebio Business Overview
Table 113. Fujirebio Respiratory Syncytial Virus Diagnostics Product
Table 114. Fujirebio Revenue in Respiratory Syncytial Virus Diagnostics Business (2016-2021) & (US$ Million)
Table 115. Fujirebio Recent Development
Table 116. Grifols Company Details
Table 117. Grifols Business Overview
Table 118. Grifols Respiratory Syncytial Virus Diagnostics Product
Table 119. Grifols Revenue in Respiratory Syncytial Virus Diagnostics Business (2016-2021) & (US$ Million)
Table 120. Grifols Recent Development
Table 121. Hoffmann La Roche Company Details
Table 122. Hoffmann La Roche Business Overview
Table 123. Hoffmann La Roche Respiratory Syncytial Virus Diagnostics Product
Table 124. Hoffmann La Roche Revenue in Respiratory Syncytial Virus Diagnostics Business (2016-2021) & (US$ Million)
Table 125. Hoffmann La Roche Recent Development
Table 126. Hologic Company Details
Table 127. Hologic Business Overview
Table 128. Hologic Respiratory Syncytial Virus Diagnostics Product
Table 129. Hologic Revenue in Respiratory Syncytial Virus Diagnostics Business (2016-2021) & (US$ Million)
Table 130. Hologic Recent Development
Table 131. Novartis Diagnostics Company Details
Table 132. Novartis Diagnostics Business Overview
Table 133. Novartis Diagnostics Respiratory Syncytial Virus Diagnostics Product
Table 134. Novartis Diagnostics Revenue in Respiratory Syncytial Virus Diagnostics Business (2016-2021) & (US$ Million)
Table 135. Novartis Diagnostics Recent Development
Table 136. Ortho Clinical Diagnostics Company Details
Table 137. Ortho Clinical Diagnostics Business Overview
Table 138. Ortho Clinical Diagnostics Respiratory Syncytial Virus Diagnostics Product
Table 139. Ortho Clinical Diagnostics Revenue in Respiratory Syncytial Virus Diagnostics Business (2016-2021) & (US$ Million)
Table 140. Ortho Clinical Diagnostics Recent Development
Table 141. Roche Diagnostics Company Details
Table 142. Roche Diagnostics Business Overview
Table 143. Roche Diagnostics Respiratory Syncytial Virus Diagnostics Product
Table 144. Roche Diagnostics Revenue in Respiratory Syncytial Virus Diagnostics Business (2016-2021) & (US$ Million)
Table 145. Roche Diagnostics Recent Development
Table 146. Scienion Company Details
Table 147. Scienion Business Overview
Table 148. Scienion Respiratory Syncytial Virus Diagnostics Product
Table 149. Scienion Revenue in Respiratory Syncytial Virus Diagnostics Business (2016-2021) & (US$ Million)
Table 150. Scienion Recent Development
Table 151. Research Programs/Design for This Report
Table 152. Key Data Information from Secondary Sources
Table 153. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Respiratory Syncytial Virus Diagnostics Market Share by Type: 2020 VS 2027
Figure 2. Direct Fluorescent Antibody Method Features
Figure 3. Rapid Antigen Diagnostic Tests Features
Figure 4. Molecular Diagnostics Features
Figure 5. Chromatographic Immunoassay Features
Figure 6. Diagnostic Imaging Features
Figure 7. Gel Microdroplets Features
Figure 8. Flow Cytometry Features
Figure 9. Other Features
Figure 10. Global Respiratory Syncytial Virus Diagnostics Market Share by Application: 2020 VS 2027
Figure 11. Hospitals Case Studies
Figure 12. Laboratory Case Studies
Figure 13. Clinics Case Studies
Figure 14. Homecare Case Studies
Figure 15. Respiratory Syncytial Virus Diagnostics Report Years Considered
Figure 16. Global Respiratory Syncytial Virus Diagnostics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 17. Global Respiratory Syncytial Virus Diagnostics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 18. Global Respiratory Syncytial Virus Diagnostics Market Share by Regions: 2020 VS 2027
Figure 19. Global Respiratory Syncytial Virus Diagnostics Market Share by Regions (2022-2027)
Figure 20. Global Respiratory Syncytial Virus Diagnostics Market Share by Players in 2020
Figure 21. Global Top Respiratory Syncytial Virus Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Respiratory Syncytial Virus Diagnostics as of 2020
Figure 22. The Top 10 and 5 Players Market Share by Respiratory Syncytial Virus Diagnostics Revenue in 2020
Figure 23. Global Respiratory Syncytial Virus Diagnostics Revenue Market Share by Type (2016-2021)
Figure 24. Global Respiratory Syncytial Virus Diagnostics Revenue Market Share by Type (2022-2027)
Figure 25. North America Respiratory Syncytial Virus Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. North America Respiratory Syncytial Virus Diagnostics Market Share by Type (2016-2027)
Figure 27. North America Respiratory Syncytial Virus Diagnostics Market Share by Application (2016-2027)
Figure 28. North America Respiratory Syncytial Virus Diagnostics Market Share by Country (2016-2027)
Figure 29. United States Respiratory Syncytial Virus Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Canada Respiratory Syncytial Virus Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Europe Respiratory Syncytial Virus Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Europe Respiratory Syncytial Virus Diagnostics Market Share by Type (2016-2027)
Figure 33. Europe Respiratory Syncytial Virus Diagnostics Market Share by Application (2016-2027)
Figure 34. Europe Respiratory Syncytial Virus Diagnostics Market Share by Country (2016-2027)
Figure 35. Germany Respiratory Syncytial Virus Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. France Respiratory Syncytial Virus Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. U.K. Respiratory Syncytial Virus Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Italy Respiratory Syncytial Virus Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Russia Respiratory Syncytial Virus Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Nordic Respiratory Syncytial Virus Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Asia-Pacific Respiratory Syncytial Virus Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Asia-Pacific Respiratory Syncytial Virus Diagnostics Market Share by Type (2016-2027)
Figure 43. Asia-Pacific Respiratory Syncytial Virus Diagnostics Market Share by Application (2016-2027)
Figure 44. Asia-Pacific Respiratory Syncytial Virus Diagnostics Market Share by Region (2016-2027)
Figure 45. China Respiratory Syncytial Virus Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Japan Respiratory Syncytial Virus Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. South Korea Respiratory Syncytial Virus Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Southeast Asia Respiratory Syncytial Virus Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. India Respiratory Syncytial Virus Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Australia Respiratory Syncytial Virus Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Latin America Respiratory Syncytial Virus Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Latin America Respiratory Syncytial Virus Diagnostics Market Share by Type (2016-2027)
Figure 53. Latin America Respiratory Syncytial Virus Diagnostics Market Share by Application (2016-2027)
Figure 54. Latin America Respiratory Syncytial Virus Diagnostics Market Share by Country (2016-2027)
Figure 55. Mexico Respiratory Syncytial Virus Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Brazil Respiratory Syncytial Virus Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Middle East & Africa Respiratory Syncytial Virus Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Middle East & Africa Respiratory Syncytial Virus Diagnostics Market Share by Type (2016-2027)
Figure 59. Middle East & Africa Respiratory Syncytial Virus Diagnostics Market Share by Application (2016-2027)
Figure 60. Middle East & Africa Respiratory Syncytial Virus Diagnostics Market Share by Country (2016-2027)
Figure 61. Turkey Respiratory Syncytial Virus Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 62. Saudi Arabia Respiratory Syncytial Virus Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 63. UAE Respiratory Syncytial Virus Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 64. Becton Dickinson Revenue Growth Rate in Respiratory Syncytial Virus Diagnostics Business (2016-2021)
Figure 65. Abbott Laboratories Revenue Growth Rate in Respiratory Syncytial Virus Diagnostics Business (2016-2021)
Figure 66. Abbott Revenue Growth Rate in Respiratory Syncytial Virus Diagnostics Business (2016-2021)
Figure 67. Beckman Coulter/Danaher Revenue Growth Rate in Respiratory Syncytial Virus Diagnostics Business (2016-2021)
Figure 68. Bio-Rad Laboratories Revenue Growth Rate in Respiratory Syncytial Virus Diagnostics Business (2016-2021)
Figure 69. Coris BioConcept Revenue Growth Rate in Respiratory Syncytial Virus Diagnostics Business (2016-2021)
Figure 70. DiaSorin SPA Revenue Growth Rate in Respiratory Syncytial Virus Diagnostics Business (2016-2021)
Figure 71. Eiken Chemical Revenue Growth Rate in Respiratory Syncytial Virus Diagnostics Business (2016-2021)
Figure 72. Elitech Revenue Growth Rate in Respiratory Syncytial Virus Diagnostics Business (2016-2021)
Figure 73. Fujirebio Revenue Growth Rate in Respiratory Syncytial Virus Diagnostics Business (2016-2021)
Figure 74. Grifols Revenue Growth Rate in Respiratory Syncytial Virus Diagnostics Business (2016-2021)
Figure 75. Hoffmann La Roche Revenue Growth Rate in Respiratory Syncytial Virus Diagnostics Business (2016-2021)
Figure 76. Hologic Revenue Growth Rate in Respiratory Syncytial Virus Diagnostics Business (2016-2021)
Figure 77. Novartis Diagnostics Revenue Growth Rate in Respiratory Syncytial Virus Diagnostics Business (2016-2021)
Figure 78. Ortho Clinical Diagnostics Revenue Growth Rate in Respiratory Syncytial Virus Diagnostics Business (2016-2021)
Figure 79. Roche Diagnostics Revenue Growth Rate in Respiratory Syncytial Virus Diagnostics Business (2016-2021)
Figure 80. Scienion Revenue Growth Rate in Respiratory Syncytial Virus Diagnostics Business (2016-2021)
Figure 81. Bottom-up and Top-down Approaches for This Report
Figure 82. Data Triangulation
Figure 83. Key Executives Interviewed
世界の呼吸器合胞体ウイルス（RSV）診断市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Respiratory Syncytial Virus (RSV) Diagnostics Market The global Respiratory Syncytial Virus (RSV) Diagnostics market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy…- 世界のデング熱ウイルス診断検査市場規模・現状・予測（2021年-2027年） Dengue is a mosquito-borne disease caused by the dengue viruses. It is a vector-borne highly communicable disease. There are four distinct but related virus serotypes all of which can cause dengue fever or the more serious forms of the disease, dengue hemorrhagic fever (DHF) and dengue shock syndrom…
- 世界のデング熱ウイルス診断検査市場規模・現状・予測（2021年-2027年） Dengue is a mosquito-borne disease caused by the dengue viruses. It is a vector-borne highly communicable disease. There are four distinct but related virus serotypes all of which can cause dengue fever or the more serious forms of the disease, dengue hemorrhagic fever (DHF) and dengue shock syndrom…
- 世界の呼吸器疾患診断検査市場規模・現状・予測（2021年-2027年） Respiratory Diseases Diagnostic Testing is the procedure to test if the patient have the Respiratory Diseases Market Analysis and Insights: Global Respiratory Diseases Diagnostic Testing Market The global Respiratory Diseases Diagnostic Testing market size is projected to reach US$ XX million by 202…
- 世界の呼吸器疾患診断検査市場規模・現状・予測（2021年-2027年） Respiratory Diseases Diagnostic Testing is the procedure to test if the patient have the Respiratory Diseases Market Analysis and Insights: Global Respiratory Diseases Diagnostic Testing Market The global Respiratory Diseases Diagnostic Testing market size is projected to reach US$ XX million by 202…